Morriston Hospital is a 750-bed hospital located in Cwmrhydyceirw near Morriston in Swansea, Wales. It is managed by Swansea Bay University Health Board. Alongside its role as a district general hospital, Morriston is a teaching hospital for medical students of Swansea University Medical School.

There are 750 beds in Morriston Hospital.

During the past decade, Morriston Hospital conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 10 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Morriston Hospital" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "University of Glasgow" with 2 trials sponsored and "Aarhus University Hospital Skejby" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Morriston Hospital" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Intensive Care National Audit & Research Centre" with 2 trials as a collaborator, "Medical Research Institute of New Zealand" with 2 trials as a collaborator, "NHS Greater Glasgow and Clyde" with 2 trials as a collaborator and "ANZICS Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Morriston Hospital" are "Atrial Fibrillation" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Heart Failure" (2 trials), "Intracranial Hemorrhages" (2 trials) and "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Morriston Hospital" in a lesser frequency.

Most popular intervention types in "Morriston Hospital" are "Drug" (26 trials), "Other" (8 trials), "Device" (7 trials), "Procedure" (7 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Ocrelizumab" (6 trials), "Edoxaban" (2 trials), "Empagliflozin" (2 trials) and "Interferon beta-1a" (2 trials). Other intervention names were less common.

The vast majority of trials in "Morriston Hospital" are 40 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Morriston Hospital". undefined are not yet recruiting, 14 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Morriston Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Morriston Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 11 trials that are defined as “Not Applicable".